Video

Traffic Pollution Can Inscreas Your Blood Pressure

A Texas Playground Caters Especially to Special Needs Children

BPA in Plastics May be Linked to Asthma

Communication Is Important When It Comes to Prostate Cancer

The Number of Home Births Has Gone Up

Which American Couples Are More Likely to Stay Together?

Workplace Wellness Can Help Reduce the Risk for Heart Problems

Some Parents May Hasten Death for Terminally Ill Children

Fitness Academics

Secondhand Smoke Increases Risk for Heart Disease in Kids

Toddlers Don't Learn Vocabulary From TV

Despite Worries, Most Parents Vaccinate Their Kids Anyway

Food Allergies Can Be Treated With the Allergen Foods

Signs of Heart Disease Could Be As Early as 3 in Obese Kids

The Number of Women Having Strokes is Rising

Study Touts Success With 'Female Viagra' Drug

Posted on 11/16/2009, 09:00
By -- Randy Dotinga

Sexual desire improves in women taking flibanserin, expert says

MONDAY, Nov. 16 (HealthDay News) -- New industry-funded research suggests that the antidepressant flibanserin, which has been touted as a female version of Viagra, can enhance libido in women with low sex drives.

The research compiles the results of several trials, the first to test a treatment for low libido in women that works on the brain, lead investigator Dr. John M. Thorp Jr., a professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill School of Medicine, said in a university news release.

"Flibanserin was a poor antidepressant," Thorp said. "However, astute observers noted that it increased libido in laboratory animals and human subjects. So, we conducted multiple clinical trials, and the women in our studies who took it for hypoactive sexual desire disorder reported significant improvements in sexual desire and satisfactory sexual experiences."

Research suggests that 9 percent to 26 percent of women in the United States suffer from low sex drive, with the numbers varying depending on age and whether they've reached menopause.

The findings were to be presented Monday at the Congress of the European Society for Sexual Medicine in Lyon, France.

The researchers combined statistics from three trials of flibanserin, which together included 1,946 premenopausal women who took either the drug or a placebo for about six months.

Daily doses of 100 milligrams significantly improved symptoms, the researchers found.

Boehringer Ingelheim, which makes flibanserin, funded the research.

More information

The American Congress of Obstetricians and Gynecologists has more on women's sexuality and sexual problems.

SOURCE: University of North Carolina School of Medicine, news release, Nov. 16, 2009

More news in Women's Health...

BigHealthTree.com Disclaimer

Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.

Rating: 3.6 / 5 (16 votes)